See analyst estimates and all valuation multiples for Chemicals
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$247B | 7.4x | 18.6x | |
$102B | 4.4x | 22.6x | |
$84.4B | 5.3x | 22.3x | |
$81.2B | 6.8x | 16.1x | |
$70.8B | 0.9x | 8.0x | |
$47.8B | 2.8x | 7.3x | |
$46.0B | 1.2x | 9.0x | |
$44.3B | 3.0x | 15.7x | |
$43.9B | 1.6x | 9.6x | |
$42.4B | 8.2x | 2737.1x | |
$40.0B | 1.5x | 6.8x | |
$37.7B | 3.0x | 11.4x | |
$34.5B | 1.1x | 9.8x | |
$33.5B | 0.8x | 8.7x | |
$32.6B | 6.9x | 18.6x | |
$32.4B | 1.0x | 6.7x | |
$31.3B | 2.0x | 11.0x | |
$29.3B | 0.9x | 9.0x | |
$27.4B | 7.0x | 38.9x | |
$27.3B | 1.8x | 10.2x | |
$23.6B | 4.1x | 10.4x | |
$23.0B | 1.9x | 11.4x | |
$22.9B | 2.1x | 10.8x | |
$22.2B | 3.5x | 9.8x | |
$21.6B | 2.4x | 10.6x | |
$19.2B | 0.5x | 2.4x | |
$19.0B | 4.7x | 15.3x | |
$18.9B | 2.5x | 15.7x | |
$17.3B | 1.4x | 10.0x | |
$17.1B | 1.7x | 8.4x | |
$16.9B | 6.7x | 22.5x | |
$16.0B | 1.0x | 14.6x | |
$15.5B | 2.6x | 12.5x | |
$15.5B | 2.4x | 5.9x | |
$14.7B | 3.0x | 11.0x | |
$14.6B | 1.2x | 8.9x | |
$14.2B | n/a | n/a | |
$13.8B | 2.0x | 8.2x | |
$13.1B | 2.6x | 12.7x | |
$12.6B | 0.8x | 5.2x | |
$12.5B | 5.3x | 11.9x | |
$12.4B | 1.4x | 7.7x | |
$12.4B | 0.7x | 5.3x | |
$11.5B | 0.8x | 10.9x | |
$11.5B | 3.6x | 9.3x | |
$10.7B | 1.4x | 6.9x | |
$10.5B | 1.0x | 70.4x | |
$10.2B | 4.8x | 23.1x | |
$9.5B | 1.8x | 8.4x | |
$8.7B | 3.1x | n/a | |
$8.7B | 0.6x | 3.1x | |
$8.6B | 0.5x | 5.3x | |
$8.5B | 2.0x | 9.4x | |
$8.1B | 0.7x | 5.0x | |
$8.0B | 1.5x | 8.3x | |
$7.7B | 1.4x | 11.5x | |
$7.5B | 3.0x | 13.8x | |
$6.8B | 0.7x | 6.5x | |
$6.7B | 3.0x | -99.9x | |
$6.5B | 2.8x | 8.2x | |
$6.5B | 0.8x | 5.7x | |
$6.4B | 1.1x | 8.1x | |
$6.3B | 0.7x | 7.9x | |
$6.3B | 1.7x | 7.3x | |
$6.1B | 0.9x | 7.9x | |
$6.0B | 6.4x | 23.9x | |
$5.7B | 22.3x | 117.0x | |
$5.7B | 6.8x | 23.9x | |
$5.6B | 1.0x | 5.0x | |
$5.6B | 1.3x | 8.9x | |
$5.5B | 2.4x | 10.4x | |
$5.3B | 1.5x | 8.7x | |
$5.3B | 1.0x | 6.2x | |
$5.3B | 1.1x | 9.1x | |
$5.2B | 2.6x | 10.2x | |
$5.2B | 5.2x | 19.6x | |
$5.2B | 3.3x | 18.5x | |
$5.2B | 1.4x | 6.4x | |
$5.2B | n/a | n/a | |
$5.1B | 0.7x | 7.7x | |
$4.9B | 1.5x | 8.9x | |
$4.6B | 5.0x | 24.4x | |
$4.5B | 0.7x | 5.8x | |
$4.4B | 1.2x | 7.5x | |
$4.3B | 1.8x | 15.1x | |
$4.0B | 2.5x | 10.1x | |
$4.0B | 0.4x | 11.4x | |
$3.9B | 0.7x | 12.5x | |
$3.9B | 3.8x | 22.1x | |
$3.8B | 1.2x | 6.0x | |
$3.8B | 1.3x | 8.3x | |
$3.8B | 7.0x | 14.1x | |
$3.8B | 1.7x | 7.7x | |
$3.7B | 0.9x | 15.3x | |
$3.7B | 1.6x | 11.7x | |
$3.7B | 1.9x | 9.7x | |
$3.7B | 2.0x | 9.1x | |
$3.6B | 1.7x | 9.4x | |
$3.6B | n/a | n/a | |
$3.4B | 2.6x | 8.8x | |
$3.2B | 1.7x | 10.5x | |
$3.2B | 11.9x | 37.2x | |
$3.1B | n/a | 97.1x | |
$2.9B | n/a | n/a | |
$2.9B | 4.7x | 25.9x | |
$2.8B | 0.4x | 4.5x | |
$2.8B | 0.8x | -7082.2x | |
$2.7B | 2.8x | 38.1x | |
$2.6B | n/a | n/a | |
$2.5B | 0.7x | 12.5x | |
$2.5B | 0.8x | 7.4x | |
$2.5B | n/a | n/a | |
$2.3B | 3.0x | 11.7x | |
$2.3B | 0.2x | 7.2x | |
$2.3B | 0.8x | 6.8x | |
$2.2B | n/a | n/a | |
$2.1B | 2.2x | 11.3x | |
$2.1B | 1.5x | 3.1x | |
$2.0B | 0.9x | 215.9x | |
$1.9B | 2.5x | 7.8x | |
$1.8B | 1.0x | 8.6x | |
$1.8B | n/a | n/a | |
$1.7B | 0.7x | 8.2x | |
$1.7B | n/a | n/a | |
$1.7B | 2.5x | 12.6x | |
$1.6B | 0.4x | 2.3x | |
$1.6B | 1.6x | 7.4x | |
$1.6B | 0.8x | 6.2x | |
$1.5B | 0.8x | 5.3x | |
$1.5B | 1.3x | 9.9x | |
$1.5B | 1.4x | 8.2x | |
$1.4B | 2.2x | 10.0x | |
$1.4B | n/a | n/a | |
$1.4B | 2.6x | n/a | |
$1.3B | 0.7x | 9.4x | |
$1.2B | 1.3x | 5.0x | |
$1.1B | 1.2x | 11.4x | |
$1.1B | 1.0x | 2.5x | |
$1.1B | 1.3x | 9.3x | |
$1.1B | 0.5x | 30.0x | |
$1.1B | 2.8x | 50.0x | |
$1.1B | 0.4x | 5.3x | |
$958M | 0.5x | 20.1x | |
$936M | 0.6x | 5.5x | |
$934M | 1.7x | 6.9x | |
$922M | 0.4x | n/a | |
$840M | 50.6x | n/a | |
$781M | n/a | n/a | |
$703M | n/a | n/a | |
$577M | 0.5x | 3.7x | |
$577M | 1.0x | 6.6x | |
$559M | n/a | n/a | |
$556M | 1.2x | 6.1x | |
$546M | 10.1x | 33.9x | |
$540M | n/a | n/a | |
$531M | 1.5x | 10.2x | |
$518M | 4.8x | -53.8x | |
$503M | 0.4x | 6.0x | |
$490M | 0.9x | 5.8x | |
$480M | 0.7x | 6.3x | |
$479M | 1.7x | -62.3x | |
$407M | 0.7x | 5.4x | |
$380M | n/a | n/a | |
$379M | 0.7x | 2.3x | |
$365M | 1.5x | 10.8x | |
$357M | 1.1x | 11.6x | |
$354M | 0.7x | 8.8x | |
$343M | 1.5x | 8.7x | |
$343M | n/a | n/a | |
$327M | 9.5x | -7.6x | |
$314M | 0.2x | 3.1x | |
$307M | 1.3x | 6.1x | |
$298M | n/a | n/a | |
$265M | n/a | n/a | |
$244M | n/a | n/a | |
$204M | n/a | n/a | |
$204M | n/a | n/a | |
$200M | 0.2x | 71.1x | |
$184M | 1.3x | n/a | |
$177M | 0.4x | 4.5x | |
$176M | 6.6x | -6.6x | |
$169M | 0.5x | 3.4x | |
$166M | 171.5x | -186.5x | |
$166M | n/a | n/a | |
$158M | n/a | n/a | |
$149M | 1.3x | 6.8x | |
$132M | 0.6x | 3.6x | |
$126M | n/a | n/a | |
$120M | 29.0x | -3.8x | |
$113M | 5.5x | 16.8x | |
$98.4M | n/a | n/a | |
$93.0M | 5.9x | -3.9x | |
$91.3M | n/a | n/a | |
$90.0M | 310.3x | -14.2x | |
$85.5M | 13.3x | -8.3x | |
$82.7M | n/a | n/a | |
$82.0M | n/a | n/a | |
$78.4M | 0.6x | 8.2x | |
$77.3M | 0.9x | n/a | |
$73.2M | n/a | n/a | |
$65.4M | 1.1x | 55.8x | |
$64.4M | 0.7x | 4.4x | |
$62.8M | n/a | n/a | |
$51.6M | 0.6x | 4.9x | |
$45.8M | 0.7x | 23.4x | |
$44.0M | 0.5x | 12.5x | |
$43.5M | 12.0x | -6.6x | |
$43.2M | n/a | n/a | |
$37.1M | 1.7x | 30.9x | |
$34.6M | n/a | n/a | |
$29.6M | 1.8x | 15.2x | |
$29.0M | n/a | n/a | |
$26.8M | n/a | n/a | |
$26.7M | 2.1x | 76.4x | |
$21.5M | n/a | n/a | |
$21.4M | 2.0x | -10.0x | |
$19.8M | n/a | n/a | |
$19.1M | n/a | n/a | |
$17.7M | n/a | n/a | |
$16.7M | n/a | n/a | |
$16.2M | n/a | n/a | |
$16.2M | n/a | n/a | |
$12.7M | n/a | n/a | |
$11.7M | 1.1x | -4.5x | |
$10.6M | 2.2x | -6.1x | |
$7.2M | n/a | n/a | |
$6.2M | 44.3x | -1.7x | |
$6.2M | 116.8x | -7.9x | |
$6.1M | n/a | n/a | |
$5.9M | n/a | n/a | |
$5.1M | n/a | n/a | |
$4.9M | 3.9x | -5.4x | |
$3.9M | n/a | n/a | |
$3.4M | n/a | n/a | |
$2.7M | n/a | n/a | |
$2.1M | n/a | n/a | |
$1.6M | n/a | n/a | |
$1.6M | n/a | n/a | |
$1.6M | 4.4x | -0.1x | |
$1.5M | n/a | n/a | |
$1.3M | n/a | n/a | |
$1.3M | n/a | n/a | |
$1.0M | n/a | n/a | |
-$5.0M | n/a | n/a | |
-$41.3M | -0.0x | -1.0x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals